Developing Therapies For Autism And Making Scientists More Translational With Dr. Mark Tepper
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
In this episode, Scott Wagers chats with Dr. Mark Tepper, CEO of EuMentis Therapeutics and a season innovator in life science and healthcare. The discussion ranges from the difficulties of developing therapies for autism to making basic scientists more translational. Mark opens up about his personal philosophy of getting through the many challenges of medical research and entrepreneurship. He also shares insights on guiding medical teams on performing in a more productive and collaborative way, leading to creative outputs that could stand the test of time.
No reviews yet